2019Proceedings of the National Academy of SciencesOpen access

Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking

Adrien Guillot, Tianyi Ren, Tony Jourdan, Robert J. Pawlosky, Elaine Han, Seung-Jin Kim, Li Zhang, George F. Koob, Bin Gao

Open full text 70 citations

Abstract

Significance It is generally accepted that ethanol and its metabolite acetaldehyde are primarily metabolized in the liver via the alcohol dehydrogenase and the aldehyde dehydrogenase-2 (ALDH2), respectively. However, by using tissue-specific Aldh2 knockout mice, we demonstrated that the liver ALDH2 is only responsible for approximately half of circulating acetaldehyde clearance after acute alcohol intake. Thus, cumulative ALDH2 activity from multiple organs may contribute to circulating acetaldehyde clearance. The present study shows that, although the liver ALDH2 only partially contributes to acetaldehyde clearance, genetic deletion or knockdown of the liver Aldh2 decreases excessive but not light to moderate alcohol drinking. Our results suggest that liver-specific ALDH2 inhibition may be an effective strategy for the treatment of alcohol user disorder with excessive drinking.

About this research paper

What this paper is about

Significance It is generally accepted that ethanol and its metabolite acetaldehyde are primarily metabolized in the liver via the alcohol dehydrogenase and the aldehyde dehydrogenase-2 (ALDH2), respectively. However, by using tissue-specific Aldh2 knockout mice, we demonstrated that the liver ALDH2 is only responsible for approximately half of circulating acetaldehyde clearance after acute alcohol intake. Thus, cumulative ALDH2 activity from multiple organs may contribute to circulating acetaldehyde clearance. The present study shows that, although the liver ALDH2 only partially contributes to acetaldehyde clearance, genetic deletion or knockdown of the liver Aldh2 decreases excessive but not light to moderate alcohol drinking. Our results suggest that liver-specific ALDH2 inhibition may be an effective strategy for the treatment of alcohol user disorder with excessive drinking.

Why it matters

OpenAlex reports 70 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Significance It is generally accepted that ethanol and its metabolite acetaldehyde are primarily metabolized in the liver via the alcohol dehydrogenase and the aldehyde dehydrogenase-2 (ALDH2), respectively. However, by using tissue-specific Aldh2 knockout mice, we demonstrated that the liver ALDH2 is only responsible for approximately half of circulating acetaldehyde clearance after acute alcohol intake. Thus, cumulative ALDH2 activity from multiple organs may contribute to circulating acetaldehyde clearance. The present study shows that, although the liver ALDH2 only partially contributes to acetaldehyde clearance, genetic deletion or knockdown of the liver Aldh2 decreases excessive but not light to moderate alcohol drinking. Our results suggest that liver-specific ALDH2 inhibition may be an effective strategy for the treatment of alcohol user disorder with excessive drinking.

Key concepts: ALDH2, Acetaldehyde, Aldehyde dehydrogenase, Alcohol dehydrogenase, Ethanol metabolism, Ethanol, Metabolite, Alcohol

Related papers

Back to paper searchBrowse research topicsOriginal source
Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking — Research Paper | ScholarLens